RecruitingNCT06075199

Intestinal Metaplasia Cohort for Gastric Cancer Prediction

A Prospective Cohort Study for Gastric Cancer Prediction in Patients With Intestinal Metaplasia


Sponsor

Seoul National University Hospital

Enrollment

1,000 participants

Start Date

Sep 13, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

In this study, we aim to establish a prospective cohort of patients with endoscopically and histologically confirmed intestinal metaplasia, collect gastric mucosal tissue samples from this cohort, and follow the development of gastric cancer over time.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking patients with intestinal metaplasia — a stomach lining change that can increase the risk of gastric (stomach) cancer — to better predict who will develop cancer and who will not. Researchers want to improve screening tools. **You may be eligible if...** - You are a patient at Seoul National University Hospital - A previous endoscopy (camera exam of the stomach) visually identified intestinal metaplasia in your stomach lining **You may NOT be eligible if...** - You have already been diagnosed with gastric cancer or stomach adenoma - You have previously had stomach surgery (like gastrectomy) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06075199


Related Trials